Physician

Bachir Farah, M.D.

According to 2025 Medicare claims, Bachir Farah, M.D. (NPI: 1336370915) practices hematology/oncology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Bond, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62269-1887. Farah is affiliated with the IRCCO (ACO ID: A2619), SSM IL ACO, LLC (ACO ID: A4832), SBL accountable care organization (ACO ID: A5147), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Farah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 487 traditional Medicare patients, billed 193,180 HCPCS/CPT codes, and received $2,849,170 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,003 prescription claims across 189 beneficiaries totaling $2,280,347 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 15 claims. Open Payments data shows 137 records totaling $2,709. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $21,756 to $2,849,170. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,005 and ending at $2,280,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	83	227	$21,756
2016	265	962	$79,014
2017	398	1,502	$123,079
2018	421	1,505	$120,976
2019	437	1,552	$127,692
2020	466	1,552	$125,883
2021	477	1,295	$128,294
2022	449	7,133	$121,223
2023	379	94,970	$863,866
2024	487	193,180	$2,849,170

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	90	$27,005
2016	113	612	$496,903
2017	173	890	$1,394,831
2018	169	1,074	$1,865,108
2019	177	979	$2,400,514
2020	181	1,079	$3,438,127
2021	187	1,052	$3,799,276
2022	151	713	$2,836,590
2023	129	492	$801,124
2024	189	1,003	$2,280,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$3,075
2017	N/R	67	$12,869
2018	N/R	58	$8,411
2019	N/R	12	$2,335
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	15	$263
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	310	1,143	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	288	621	$13
80053	Blood test, comprehensive group of blood chemicals	223	910	$10
36415	Insertion of needle into vein for collection of blood sample	284	927	$9
85007	Microscopic examination for white blood cells with manual cell count	187	714	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	26	644	$391,664
Sprycel	Dasatinib	21	605	$320,295
Jakafi	Ruxolitinib Phosphate	14	420	$228,830
Imbruvica	Ibrutinib	13	364	$212,772
Ibrance	Palbociclib	13	364	$203,255

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	137	$2,709	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bachir Farah, M.D.?

Tedicare shows public-source Medicare data for Bachir Farah, M.D. (NPI 1336370915), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bachir Farah, M.D. have ACO affiliation data?

Bachir Farah, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), SSM IL ACO, LLC (MSSP, ACO ID A4832), SBL accountable care organization (MSSP, ACO ID A5147), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Bachir Farah, M.D.?

Bachir Farah, M.D. is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Bachir Farah, M.D. have Open Payments data?

Bachir Farah, M.D. has 137 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.